Kaposi's sarcoma - Associated herpesvirus: A new DNA tumor virus

被引:98
作者
Boshoff, C
Chang, Y
机构
[1] UCL, Sir Jules Thorn Inst, Dept Oncol, CRC Viral Oncol Grp, London W1N 8AA, England
[2] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
来源
ANNUAL REVIEW OF MEDICINE | 2001年 / 52卷
关键词
KSHV; HHV8; primary effusion lymphoma; Castleman's disease;
D O I
10.1146/annurev.med.52.1.453
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV) is a newly identified gammaherpesvirus associated with all clinical forms of Kaposi's sarcoma (KS), body-cavity-based, primary effusion lymphomas (PELs), and a subset of Castleman's disease (CD). Sequence analysis of the KSHV genome demonstrates an extensive array of genes with homology to cellular genes involved in cell cycle regulation, cell proliferation, apoptosis, and immune modulation. Functional studies indicate that these genes may modify the host cell environment, contributing to the pathogenesis of KSHV-associated disorders. Several KSHV genes have been found to cause dysregulated cell proliferation or to interfere with established tumor suppressor pathways. The epidemiologic association of KSHV with malignancies and the coding features of its genome suggest that it is a new DNA tumor virus.
引用
收藏
页码:453 / 470
页数:18
相关论文
共 147 条
[1]   HERPES-LIKE SEQUENCES IN HIV-INFECTED AND UNINFECTED KAPOSIS-SARCOMA PATIENTS [J].
AMBROZIAK, JA ;
BLACKBOURN, DJ ;
HERNDIER, BG ;
GLOGAU, RG ;
GULLETT, JH ;
MCDONALD, AR ;
LENNETTE, ET ;
LEVY, JA .
SCIENCE, 1995, 268 (5210) :582-583
[2]   Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 [J].
Aoki, Y ;
Jaffe, ES ;
Chang, Y ;
Jones, K ;
Teruya-Feldstein, J ;
Moore, PS ;
Tosato, G .
BLOOD, 1999, 93 (12) :4034-4043
[3]   Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [J].
Arvanitakis, L ;
GerasRaaka, E ;
Varma, A ;
Gershengorn, MC ;
Cesarman, E .
NATURE, 1997, 385 (6614) :347-350
[4]   Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus [J].
Arvanitakis, L ;
Mesri, EA ;
Nador, RG ;
Said, JW ;
Asch, AS ;
Knowles, DM ;
Cesarman, E .
BLOOD, 1996, 88 (07) :2648-2654
[5]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[6]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644
[7]  
BATES S, 1994, ONCOGENE, V9, P1633
[8]  
BERAL V, 1991, CANCER HIV AIDS, P5
[9]   Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis [J].
Bertin, J ;
Armstrong, RC ;
Ottilie, S ;
Martin, DA ;
Wang, Y ;
Banks, S ;
Wang, GH ;
Senkevich, TG ;
Alnemri, ES ;
Moss, B ;
Lenardo, MJ ;
Tomaselli, KJ ;
Cohen, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1172-1176
[10]  
BODRUG SE, 1995, CELL DEATH DIFFER, V2, P173